Cargando…

The role of surgery for pancreatic cancer: a 12-year review of patient outcome

INTRODUCTION: Pancreatic cancer has a poor prognosis with <5% alive at 5 years, despite active surgical treatment. The study aim was to review patients undergoing pancreatic resection and assess the effect of clinical and pathological parameters on survival. PATIENTS AND METHODS: All patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Badger, SA, Brant, JL, Jones, C, McClements, J, Loughrey, MB, Taylor, MA, Diamond, T, McKie, LD
Formato: Texto
Lenguaje:English
Publicado: The Ulster Medical Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993146/
https://www.ncbi.nlm.nih.gov/pubmed/21116422
_version_ 1782192810504486912
author Badger, SA
Brant, JL
Jones, C
McClements, J
Loughrey, MB
Taylor, MA
Diamond, T
McKie, LD
author_facet Badger, SA
Brant, JL
Jones, C
McClements, J
Loughrey, MB
Taylor, MA
Diamond, T
McKie, LD
author_sort Badger, SA
collection PubMed
description INTRODUCTION: Pancreatic cancer has a poor prognosis with <5% alive at 5 years, despite active surgical treatment. The study aim was to review patients undergoing pancreatic resection and assess the effect of clinical and pathological parameters on survival. PATIENTS AND METHODS: All patients who had undergone radical pancreatic surgery, January 1996 to December 2008, were identified from the unit database. Additional information was retrieved from the patient records. The demographic, clinical, and pathological records were recorded using Microsoft Excel. Survival was assessed using Kaplan-Meier and predictors of survival determined by multinominal logistic regression and log rank test. RESULTS: 126 patients were identified from the database. The majority (106) had a Whipple's procedure, 14 had a distal pancreatectomy and 6 had local periampullary excision. The average age of the Whipple's group of patients was 61.7 years (± 11.7) with most procedures performed for malignancy (n=100). Survival was worse with adenocarcinoma compared to all other pathologies (p=0.013), while periampullary tumours had a better prognosis compared to other locations (p=0.019). Survival decreased with poorer differentiation (p=0.001), increasing pT (p<0.001) and pN stage (p<0.001). Survival was worse with perineural (p=0.04) or lymphovascular invasion (p=0.05). A microscopic postive resection margin (R1) was associated with a worse survival (p=0.007). Tumour differentiation (p=0.001) and positive nodal status (p<0.001) were found to be independent predictors of mortality. CONCLUSION: Tumour differentiation and nodal status are important predictors of outcome. A positive resection margin is associated with a poorer survival.
format Text
id pubmed-2993146
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Ulster Medical Society
record_format MEDLINE/PubMed
spelling pubmed-29931462010-11-29 The role of surgery for pancreatic cancer: a 12-year review of patient outcome Badger, SA Brant, JL Jones, C McClements, J Loughrey, MB Taylor, MA Diamond, T McKie, LD Ulster Med J Paper INTRODUCTION: Pancreatic cancer has a poor prognosis with <5% alive at 5 years, despite active surgical treatment. The study aim was to review patients undergoing pancreatic resection and assess the effect of clinical and pathological parameters on survival. PATIENTS AND METHODS: All patients who had undergone radical pancreatic surgery, January 1996 to December 2008, were identified from the unit database. Additional information was retrieved from the patient records. The demographic, clinical, and pathological records were recorded using Microsoft Excel. Survival was assessed using Kaplan-Meier and predictors of survival determined by multinominal logistic regression and log rank test. RESULTS: 126 patients were identified from the database. The majority (106) had a Whipple's procedure, 14 had a distal pancreatectomy and 6 had local periampullary excision. The average age of the Whipple's group of patients was 61.7 years (± 11.7) with most procedures performed for malignancy (n=100). Survival was worse with adenocarcinoma compared to all other pathologies (p=0.013), while periampullary tumours had a better prognosis compared to other locations (p=0.019). Survival decreased with poorer differentiation (p=0.001), increasing pT (p<0.001) and pN stage (p<0.001). Survival was worse with perineural (p=0.04) or lymphovascular invasion (p=0.05). A microscopic postive resection margin (R1) was associated with a worse survival (p=0.007). Tumour differentiation (p=0.001) and positive nodal status (p<0.001) were found to be independent predictors of mortality. CONCLUSION: Tumour differentiation and nodal status are important predictors of outcome. A positive resection margin is associated with a poorer survival. The Ulster Medical Society 2010-05 /pmc/articles/PMC2993146/ /pubmed/21116422 Text en © The Ulster Medical Society, 2010
spellingShingle Paper
Badger, SA
Brant, JL
Jones, C
McClements, J
Loughrey, MB
Taylor, MA
Diamond, T
McKie, LD
The role of surgery for pancreatic cancer: a 12-year review of patient outcome
title The role of surgery for pancreatic cancer: a 12-year review of patient outcome
title_full The role of surgery for pancreatic cancer: a 12-year review of patient outcome
title_fullStr The role of surgery for pancreatic cancer: a 12-year review of patient outcome
title_full_unstemmed The role of surgery for pancreatic cancer: a 12-year review of patient outcome
title_short The role of surgery for pancreatic cancer: a 12-year review of patient outcome
title_sort role of surgery for pancreatic cancer: a 12-year review of patient outcome
topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993146/
https://www.ncbi.nlm.nih.gov/pubmed/21116422
work_keys_str_mv AT badgersa theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT brantjl theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT jonesc theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT mcclementsj theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT loughreymb theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT taylorma theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT diamondt theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT mckield theroleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT badgersa roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT brantjl roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT jonesc roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT mcclementsj roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT loughreymb roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT taylorma roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT diamondt roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome
AT mckield roleofsurgeryforpancreaticcancera12yearreviewofpatientoutcome